glp 1 is semaglutide Comparing Ozempic, Wegovy and Other GLP-1 Drugs Semaglutide for Weight Loss -

Are there documented human cases of thyroid cancer from Ozempic

DiSilvestro RA, Dardenne M, Joseph E

But be cautious in their use, if using at all

In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support

For retirees, GLP-1 medications offer: Significant weight loss (15-21% in trials at maximum doses)

Glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists reduce body weight, glycaemia, blood pressure, postprandial lipaemia and inflammation actions that could contribute to the reduction of cardiovascular events